Network Reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data from Cancer Cells

被引:6
作者
Buffard, Marion [1 ,2 ]
Naldi, Aurelien [3 ]
Radulescu, Ovidiu [2 ]
Coopman, Peter J. [1 ]
Larive, Romain M. [4 ]
Freiss, Gilles [1 ]
机构
[1] Univ Montpellier, INSERM, ICM, IRCM, F-34298 Montpellier, France
[2] Univ Montpellier, CNRS, LPHI, F-34095 Montpellier, France
[3] PSL Univ, Computat Syst Biol Team, Inst Biol, Ecole Normale Super,CNRS,UMR8197,INSERM,U1024, F-75230 Montpellier, France
[4] Univ Montpellier, ENSCM, CNRS, IBMM, F-34093 Montpellier, France
关键词
data processing and analysis; oncogenic signaling; phosphoproteomics; phosphatidyl-inositol 3-kinase enzyme; Src-related tyrosine kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylation sites; PIK3CA; KINASE; PHOSPHORYLATION; MUTATIONS; GENE; KEGG;
D O I
10.1002/pmic.201800450
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphorylation acts as an efficient switch controlling deregulated key signaling pathway in cancer. Computational biology aims to address the complexity of reconstructed networks but overrepresents well-known proteins and lacks information on less-studied proteins. A bioinformatic tool to reconstruct and select relatively small networks that connect signaling proteins to their targets in specific contexts is developed. It enables to propose and validate new signaling axes of the Syk kinase. To validate the potency of the tool, it is applied to two phosphoproteomic studies on oncogenic mutants of the well-known phosphatidyl-inositol 3-kinase (PIK3CA) and the unfamiliar Src-related tyrosine kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylation sites (SRMS) kinase. By combining network reconstruction and signal propagation, comprehensive signaling networks from large-scale experimental data are built and multiple molecular paths from these kinases to their targets are extracted. Specific paths from two distinct PIK3CA mutants are retrieved, and their differential impact on the HER3 receptor kinase is explained. In addition, to address the missing connectivities of the SRMS kinase to its targets in interaction pathway databases, phospho-tyrosine and phospho-serine/threonine proteomic data are integrated. The resulting SRMS-signaling network comprises casein kinase 2, thereby validating its currently suggested role downstream of SRMS. The computational pipeline is publicly available, and contains a user-friendly graphical interface ().
引用
收藏
页数:8
相关论文
共 29 条
  • [1] The PIK3CA gene is mutated with high frequency in human breast cancers
    Bachman, KE
    Argani, P
    Samuels, Y
    Silliman, N
    Ptak, J
    Szabo, S
    Konishi, H
    Karakas, B
    Blair, BG
    Lin, C
    Peters, BA
    Velculescu, VE
    Park, BH
    [J]. CANCER BIOLOGY & THERAPY, 2004, 3 (08) : 772 - 775
  • [2] Cancer-specific mutations in PIK3CA are oncogenic in vivo
    Bader, AG
    Kang, SY
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1475 - 1479
  • [3] A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations
    Blair, Brian G.
    Wu, Xinyan
    Zahari, Muhammad Saddiq
    Mohseni, Morassa
    Cidado, Justin
    Wong, Hong Yuen
    Beaver, Julia A.
    Cochran, Rory L.
    Zabransky, Daniel J.
    Croessmann, Sarah
    Chu, David
    Toro, Patricia Valda
    Cravero, Karen
    Pandey, Akhilesh
    Park, Ben Ho
    [J]. PROTEOMICS, 2015, 15 (2-3) : 318 - 326
  • [4] Phosphorylation of 20S proteasome alpha subunit C8 (α7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by γ-interferon
    Bose, S
    Stratford, FLL
    Broadfoot, KI
    Mason, GGF
    Rivett, AJ
    [J]. BIOCHEMICAL JOURNAL, 2004, 378 : 177 - 184
  • [5] Buffard M., 2017, JOBIM M, P138
  • [6] Pathway Commons, a web resource for biological pathway data
    Cerami, Ethan G.
    Gross, Benjamin E.
    Demir, Emek
    Rodchenkov, Igor
    Babur, Oezguen
    Anwar, Nadia
    Schultz, Nikolaus
    Bader, Gary D.
    Sander, Chris
    [J]. NUCLEIC ACIDS RESEARCH, 2011, 39 : D685 - D690
  • [7] MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
    Engelman, Jeffrey A.
    Zejnullahu, Kreshnik
    Mitsudomi, Tetsuya
    Song, Youngchul
    Hyland, Courtney
    Park, Joon Oh
    Lindeman, Neal
    Gale, Christopher-Michael
    Zhao, Xiaojun
    Christensen, James
    Kosaka, Takayuki
    Holmes, Alison J.
    Rogers, Andrew M.
    Cappuzzo, Federico
    Mok, Tony
    Lee, Charles
    Johnson, Bruce E.
    Cantley, Lewis C.
    Janne, Pasi A.
    [J]. SCIENCE, 2007, 316 (5827) : 1039 - 1043
  • [8] The Reactome Pathway Knowledgebase
    Fabregat, Antonio
    Jupe, Steven
    Matthews, Lisa
    Sidiropoulos, Konstantinos
    Gillespie, Marc
    Garapati, Phani
    Haw, Robin
    Jassal, Bijay
    Korninger, Florian
    May, Bruce
    Milacic, Marija
    Roca, Corina Duenas
    Rothfels, Karen
    Sevilla, Cristoffer
    Shamovsky, Veronica
    Shorser, Solomon
    Varusai, Thawfeek
    Viteri, Guilherme
    Weiser, Joel
    Wu, Guanming
    Stein, Lincoln
    Hermjakob, Henning
    D'Eustachio, Peter
    [J]. NUCLEIC ACIDS RESEARCH, 2018, 46 (D1) : D649 - D655
  • [9] The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1
    Goel, Raghuveera K.
    Miah, Sayem
    Black, Kristin
    Kalra, Natasha
    Dai, Chenlu
    Lukong, Kiven E.
    [J]. FEBS JOURNAL, 2013, 280 (18) : 4539 - 4559
  • [10] Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates
    Goel, Raghuveera Kumar
    Meyer, Mona
    Paczkowska, Marta
    Reimand, Juri
    Vizeacoumar, Frederick
    Vizeacoumar, Franco
    Lam, TuKiet T.
    Lukong, Kiven Erique
    [J]. PROTEOME SCIENCE, 2018, 16